Peijia Medical's 2025 Interim Results Reveal Revenue Growth and New Innovations Peijia Medical reports strong revenue growth in H1 2025, showing improved profitability and substantial advancements in transcatheter valve products and neurointerventional technologies.

Peijia Medical's 2025 Interim Results Reveal Revenue Growth and New Innovations #China #Suzhou #Peijia_Medical #Neurointerventional #TAVR_system